Biologics

Robert LaPrade, MD, PhD, a complex knee and sports medicine surgeon, joined Golden Valley, Minn.-based Twin Cities Orthopedics June 3. 

Ottawa, Canada-based biomaterials startup Spiderwort closed a $500,000 oversubscribed friends and family funding round, reports BetaKit.

Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber.

Regenerative medicine and cell therapy company InGeneron extended its Series D financing by up to $23 million, totaling $43 million, to be invested in the company.

Konica Minolta Healthcare is hosting an autologous biologics workshop in collaboration with EmCyte to support education for ultrasound-guided musculoskeletal inventions.

Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis.

Scottsdale, Ariz.-based R3 Stem Cell responded to an FDA letter that raised safety and legality concerns over R3's stem cell offerings.

A federal judge granted the FDA authority to regulate treatments from U.S. Stem Cell Clinic and U.S. Stem Inc., NBC News reports.

Niagara Falls (N.Y.) Memorial Medical Center and Andrew Cappuccino, MD, of Buffalo (N.Y.) Spine Surgery are opening a stem cell therapy center, reports WNY Papers.com.

A new study published in The Spine Journal examines outcomes from posterior lumbar fusions at a physician-owned hospital compared with a non-physician-owned hospital.